Tear Fluid Progranulin as a Noninvasive Biomarker for the Monitoring of Corneal Innervation Changes in Patients With Type 2 Diabetes Mellitus
Translational Vision Science & Technology · 2024
DOI: 10.1167/tvst.13.7.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2024. Verfasst von Tianyi Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Tears, Progranulins, Biomarkers, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.
Zitieren
APA
Zhou, T., Dou, Z., Cai, Y., Zhu, D., & Fu, Y. (2024). Tear Fluid Progranulin as a Noninvasive Biomarker for the Monitoring of Corneal Innervation Changes in Patients With Type 2 Diabetes Mellitus. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.13.7.9
Vancouver
Zhou T, Dou Z, Cai Y, Zhu D, Fu Y. Tear Fluid Progranulin as a Noninvasive Biomarker for the Monitoring of Corneal Innervation Changes in Patients With Type 2 Diabetes Mellitus. Translational Vision Science & Technology. 2024. doi:10.1167/tvst.13.7.9
BibTeX
@article{Zhou2024,
author = {Zhou, Tianyi and Dou, Zhiwei and Cai, Yuchen and Zhu, Dongqing and Fu, Yao},
title = {Tear Fluid Progranulin as a Noninvasive Biomarker for the Monitoring of Corneal Innervation Changes in Patients With Type 2 Diabetes Mellitus},
journal = {Translational Vision Science & Technology},
year = {2024},
doi = {10.1167/tvst.13.7.9}
}
EUVIMED